Diversified Healthcare ParagonCare serves Australia, New Zealand and Asia with equipment, devices and consumables across acute and ancillary care, presenting opportunities to upsell maintenance, repair services and diagnostic reagents alongside product sales to expand geographic reach.

Aesthetic Expansion Active involvement in aesthetics through ParagonCare Aesthetics and partnerships (Classys) signals demand for cosmetic medical devices and related consumables, offering cross-sell potential into clinics and dermatology practices seeking quality equipment and hosting events to drive trials.

Strategic Partnerships Recent collaborations with Coreline Soft for AI-driven lung cancer screening and distribution agreements (MacuMira via Keeler) indicate a pathway to bundle diagnostic software, imaging devices and reagents, creating multi-product solutions for oncology and ophthalmology channels.

Dental and Diagnostics Push Launch of ParagonCare Dental plus sovereign blood bank reagent manufacturing highlights segments ripe for expansion into dental practices and labs, with opportunities to bundle equipment, consumables and in-house maintenance services.

Growth through Federalization Revenue in the mid-market range (25–50 million) combined with a broad tech stack (AWS, SAP, SQL Server, HubSpot) supports scalable sales motions, CRM-driven targeting and cross-sell of service contracts, software-enabled diagnostics, and maintenance offerings to existing hospital networks.